Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to tr... Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to treat a rare monogenic muscle disease. Show more
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire SAN DIEGO, Dec. 20, 2024 SAN DIEGO, Dec. 20, 2024 /PRNewswire/ -- Avidity Biosciences, Inc...
Avidity Biosciences to Participate in Upcoming Investor Conference PR Newswire SAN DIEGO, Nov. 26, 2024 SAN DIEGO, Nov. 26, 2024 /PRNewswire/ -- Avidity Biosciences, Inc. (Nasdaq: RNA), a...
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire SAN DIEGO, Nov. 21, 2024 SAN DIEGO, Nov. 21, 2024 /PRNewswire/ --Β Avidity Biosciences, Inc...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.6 | -1.92926045016 | 31.1 | 31.85 | 28.32 | 1312259 | 29.82209538 | CS |
4 | -6.1121 | -16.6942076527 | 36.6121 | 38.8575 | 28.32 | 1350152 | 32.42427438 | CS |
12 | -13.61 | -30.8546814781 | 44.11 | 56 | 28.32 | 1120660 | 40.25017045 | CS |
26 | -8.06 | -20.9024896266 | 38.56 | 56 | 28.32 | 1265349 | 42.55842274 | CS |
52 | 21.28 | 230.802603037 | 9.22 | 56 | 8.965 | 1298143 | 33.82016708 | CS |
156 | 6.71 | 28.2051282051 | 23.79 | 56 | 4.825 | 1034792 | 22.30052051 | CS |
260 | 11.85 | 63.5388739946 | 18.65 | 56 | 4.825 | 768938 | 22.64429024 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.